This website is intended for healthcare professionals only.

Newsletter      
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

Pathology and diagnostics

Skin rashes help to identify cases of COVID-19
Guide to safely resume cardiovascular procedures during COVID-19 issued
New understanding of asthma medicines could improve future treatment
Experimental tool predicts which COVID-19 patients develop respiratory disease
Molecular imaging could transform management of patients with aggressive cancer
Redefining non-alcoholic fatty liver disease
Researchers discover prostate cancer ‘fingerprint’
Urine test could reduce unnecessary prostate cancer biopsies
New technology for cancer diagnostics and drug testing
Digital heart model could help predict future heart health
Research uncovers new path for melanoma detection and treatment
Staff shortages mean patients could miss out on early bowel cancer diagnosis
Portable device aids faster diagnosis of sepsis
Test enables easier and faster detection of coeliac disease antibodies


Popular articles

Aspirin use associated with improved survival but only for bladder and breast cancer
Metformin use in diabetes protective against COVID-19-related mortality
Low levels of alcohol intake linked to greater risk of atrial fibrillation
Bimagrumab leads to significant fat loss in obese, type 2 diabetic patients
Higher convalescent plasma antibody titre levels associated with lower risk of death in COVID-19




 
Hospital Healthcare Europe
 
LinkedIn Logo Footer  Twitter Logo Footer

Ⓒ Cogora 2021
Cogora Limited, 140 London Wall, London EC2Y 5DN, Registered in the United Kingdom. Reg. No. 2147432

Hospital Healthcare Europe
HOPE Logo Footer